Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)

NCT02842320 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire de Besancon